CRBU

Caribou Biosciences, Inc.

CRBU · CIK 1619856 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$10M
20212024
Net Income−$149M
20212024
Operating CF−$138M
20212024
Free Cash Flow−$143M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.0B$0.0B$0.0B$0.0B
Cost of Revenue————
Gross Profit————
R&D Expense$0.1B$0.1B$0.1B$0.0B
SG&A Expense————
Operating Income$-0.2B$-0.1B$-0.1B$-0.0B
Net Income$-0.1B$-0.1B$-0.1B$-0.0B
EPS (Basic)$-1.65$-1.38$-1.64—
EPS (Diluted)$-1.65$-1.38$-1.64—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.3B$0.4B$0.4B$0.4B
Current Assets$0.2B$0.3B$0.3B$0.4B
Cash & Equivalents$0.0B$0.1B$0.1B$0.2B
Total Liabilities$0.1B$0.1B$0.1B$0.1B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.3B$0.4B$0.3B$0.4B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.1B$-0.1B$-0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.2B$0.0B$0.4B
← Companies